✦ LIBER ✦

Cryoprecipitate-removed plasma ‘cryo-removed plasma’ as a source of factor IX in the treatment of haemophilia B

✍ Scribed by L. M. P. Lepatan; F. G. Hernandez; M. M. Montoya; J. B. Ong; E. V. Rodriguez; M. N. Chua

Book ID: 108769446
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 58 KB
Volume: 10
Category: Article
ISSN: 1351-8216
DOI: 10.1111/j.1365-2516.2004.00884.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Characterisation of the tolerant state i

Characterisation of the tolerant state in a patient with haemophilia B after removal of high-titre factor IX antibodies

✍ Zettervall, Olle ;Sundqvist, Siv-Britt ;Nilsson, Inga Marie 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) ⚖ 521 KB

Removal and inactivation of viruses duri

Removal and inactivation of viruses during the manufacture of a high-purity antihemophilic factor IX from human plasma

✍ In Seop Kim; Jung Eun Bae; Hark Mo Sung; Yong Kang; Yong Woon Choi 📂 Article 📅 2009 🏛 The Korean Society for Biotechnology and Bioengine 🌐 English ⚖ 459 KB

Influence of factor IX on overall plasma

Influence of factor IX on overall plasma coagulability and fibrinolytic potential as measured by global assay: monitoring in haemophilia B

✍ N. A. GOLDENBERG; C. BOMBARDIER; W. E. HATHAWAY; K. McFARLAND; L. JACOBSON; M. J 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB

Therapeutic plasma concentrations of hum

Therapeutic plasma concentrations of human factor IX in mice after gene delivery into the amniotic cavity: a model for the prenatal treatment of haemophilia B

✍ Holm Schneider; Sheri Adebakin; Michael Themis; Terry Cook; Anne Marie Douar; An 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB 👁 2 views

Background Several groups including our own have reported gene delivery to fetal organs by vector administration into the amniotic cavity. Based on these studies we hypothesised that the large surface of the fetal skin may be exploitable for high level production of systemically required gene produc

Clinical efficacy, safety and pharmacoki

Clinical efficacy, safety and pharmacokinetic properties of the plasma-derived factor IX concentrate Haemonine® in previously treated patients with severe haemophilia B

✍ M. SERBAN; A. B. SKOTNICKI; M. COLOVIC; C. JINCA; A. KLUKOWSKA; P. LAGUNA; D. M. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Ratio of invaded to removed lymph nodes

Ratio of invaded to removed lymph nodes as a prognostic factor in adenocarcinoma of the distal esophagus and esophagogastric junction

✍ S. Saha; T. C. B. Dehn 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB